Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Arch Capital Group Ltd.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $31.9B |
|---|
| Revenue (ttm) | 18.8B |
|---|
| Net income (ttm) | 4.3B |
|---|
| EPS (ttm) | $12.3 |
|---|
| Shares out | 339.8M |
|---|
| P/E (trailing) | 8.3x |
|---|
| P/E (forward) | 9.6x |
|---|
| Volume | 2,463,099 |
|---|
| Beta | 0.26 |
|---|
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $9.25B | $9.61B | $13.63B | $17.44B | $19.93B | +21.2% |
| Gross profit | $3.04B | $2.89B | $4.74B | $6.45B | $7.41B | +25.0% |
| Operating income | $2.24B | $1.62B | $3.52B | $4.62B | $5.16B | +23.2% |
| Net income | $2.16B | $1.48B | $4.44B | $4.31B | $4.40B | +19.5% |
| EPS (diluted) | $5.23 | $3.80 | $11.62 | $11.19 | $11.60 | +22.0% |
| EBITDA | $2.32B | $1.72B | $3.61B | $4.85B | $5.35B | +23.2% |
| R&D | — | — | — | — | — | — |
| SG&A | $78.0M | $95.0M | $102.0M | $1.67B | $79.0M | +0.3% |
Recent company headlines from major financial publishers.
Arch executes disciplined cycle management across property lines, ceding softening property cat reinsurance exposure while maintaining firm casualty margins and mortgage underwriting profitability. Operating cash flows remain robust, funding accretive share repurchases that drive per-share book value and EPS compounding.
Discipline in commercial casualty pricing hardens broader property and casualty lines, while property cat reinsurance rates stabilize. Synergies from the MCE acquisition materialize faster than projected, lowering the expense ratio, while mortgage credit performance remains pristine and reinvestment yields bolster net investment income.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 5.9% | $166 | $173 | $181 | $191 | $202 |
| 6.4% | $152 | $157 | $163 | $170 | $178 |
| 6.9% | $141 | $145 | $149 | $154 | $160 |
| 7.4% | $131 | $135 | $138 | $142 | $147 |
| 7.9% | $123 | $126 | $129 | $132 | $136 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |